| DNA helicase activity of SV40 large tumor antigen. H Stahl, P Dröge, R Knippers The EMBO journal 5 (8), 1939-1944, 1986 | 543 | 1986 |
| Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity Z Adhireksan, GE Davey, P Campomanes, M Groessl, CM Clavel, H Yu, ... Nature communications 5 (1), 3462, 2014 | 322 | 2014 |
| A bacterial enhancer functions to tether a transcriptional activator near a promoter A Wedel, DS Weiss, D Popham, P Dröge, S Kustu Science 248 (4954), 486-490, 1990 | 246 | 1990 |
| Policy, financing and implementation C Mitchell, J Sawin, GR Pokharel, DM Kammen, Z Wang, S Fifita, ... IPCC special report on renewable energy sources and climate change mitigation, -, 2011 | 164 | 2011 |
| Denaturing urea polyacrylamide gel electrophoresis (Urea PAGE) H Summer, R Grämer, P Dröge JoVE (Journal of Visualized Experiments), e1485, 2009 | 143 | 2009 |
| Transactivation of the Xenopus rRNA gene promoter by its enhancer M Dunaway, P Dröge Nature 341 (6243), 657-659, 1989 | 139 | 1989 |
| The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? K Pfannkuche, H Summer, O Li, J Hescheler, P Dröge Stem Cell Reviews and Reports 5, 224-230, 2009 | 127 | 2009 |
| Site selectivity of platinum anticancer therapeutics B Wu, P Dröge, CA Davey Nature chemical biology 4 (2), 110-112, 2008 | 92 | 2008 |
| Protein tracking‐induced supercoiling of DNA: A tool to regulate DNA transactions in vivo? P Dröge Bioessays 16 (2), 91-99, 1994 | 90 | 1994 |
| HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy H Summer, O Li, Q Bao, L Zhan, S Peter, P Sathiyanathan, D Henderson, ... Nucleic acids research 37 (13), 4371-4384, 2009 | 89 | 2009 |
| Monoclonal antibodies as probes for a function of large T antigen during the elongation process of simian virus 40 DNA replication M Wiekowski, P Dröge, H Stahl Journal of virology 61 (2), 411-418, 1987 | 86 | 1987 |
| A large-tumor-antigen-specific monoclonal antibody inhibits DNA replication of simian virus 40 minichromosomes in an in vitro elongation system H Stahl, P Dröge, H Zentgraf, R Knippers Journal of virology 54 (2), 473-482, 1985 | 84 | 1985 |
| High‐level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells O Li, D Vasudevan, CA Davey, P Dröge genesis 44 (11), 523-529, 2006 | 76 | 2006 |
| High local protein concentrations at promoters: strategies in prokaryotic and eukaryotic cells P Dröge, B Müller‐Hill Bioessays 23 (2), 179-183, 2001 | 76 | 2001 |
| Site-specific recombination in human cells catalyzed by phage λ integrase mutants E Lorbach, N Christ, M Schwikardi, P Dröge Journal of Molecular Biology 296 (5), 1175-1181, 2000 | 74 | 2000 |
| Human genomic Z-DNA segments probed by the Zα domain of ADAR1 H Li, J Xiao, J Li, L Lu, S Feng, P Dröge Nucleic acids research 37 (8), 2737-2746, 2009 | 73 | 2009 |
| DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells O Li, J Li, P Dröge FEBS letters 581 (18), 3533-3537, 2007 | 73 | 2007 |
| Parallel bimodal single-cell sequencing of transcriptome and chromatin accessibility QR Xing, CA El Farran, YY Zeng, Y Yi, T Warrier, P Gautam, JJ Collins, ... Genome Research 30 (7), 1027-1039, 2020 | 67 | 2020 |
| The human genome-wide distribution of DNA palindromes L Lu, H Jia, P Dröge, J Li Functional & integrative genomics 7, 221-227, 2007 | 67 | 2007 |
| HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells S Natarajan, S Hombach-Klonisch, P Dröge, T Klonisch Neoplasia 15 (3), 263-IN13, 2013 | 66 | 2013 |
